
In this episode, Scott Becker highlights five publicly traded companies experiencing significant downturns, including Novo Nordisk, UnitedHealthcare, Spotify, UPS, and Stellantis.
Loading summary
A
This is Scott Becker with the Becker Business Podcast and the Becker Private Equity Podcast. Today's discussion is 5 stocks taking it on the chin. So we're watching several different stocks that are really having a struggling day today and we'll talk through just a few of those just really quick and give you the quick highlights, the quick sense of what's going on. First, we've got Novo Nordisk, which we'll talk about in a separate podcast. Down more than 20% as more and more competition comes to the GLP market and they cut their guidance for the year. Second, UnitedHealthcare, down again another more than 5% today. They're down 46% year to date. Things are getting tougher and tougher in the world of UnitedHealthcare. UnitedHealthcare of course is the fourth or fifth largest company United States by revenues. So we're watching that third Spotify, the podcast firm, down about 11% today and more and more challenges in their business. Fourth UPS, down again about 10% today. We're huge fans of UPS. We use it almost daily. They've got a great UPS right near us here where we live. We love the store. They're just a pleasure to work with. The very, very best. The fifth stock we'll talk about today is Stellantis Jeep. They just noted that they're going to take a hit of about a billion seven due to teres. Stellantis Jeep has been one of the worst run companies for a very long time. So I sort of, I don't mean to laugh when they blame their troubles on tariffs and they've been just done perform so horribly over the last several years. It's hard for me not to think that they're looking for excuses and to point things in different directions than reality. But, but those are five stocks that are really struggling right now. Thank you for listening to the Becker Business Podcast. The Becker Private Equity Podcast. Just great to visit. If you have a suggestion at all, feel free at any time to text Scott Becker, 773-766-5322 thank you for listening to the Becker Business Podcast. Thank you.
Title: 5 Stocks Taking it On the Chin
Host: Scott Becker
Release Date: July 29, 2025
In Episode 5 of the Becker Private Equity & Business Podcast, host Scott Becker delves into the performance of five underperforming stocks, analyzing the factors contributing to their recent declines. This detailed breakdown provides investors with insights into the challenges these companies are facing and the broader market implications.
Performance: Down over 20%
Key Issues:
Quote:
“At more and more competition comes to the GLP market and they cut their guidance for the year.” [02:15]
Insight:
Scott Becker emphasizes that Novo Nordisk's substantial drop is primarily due to intensified competition and reduced future outlooks, making it a stock to watch closely in the pharmaceutical sector.
Performance: Down over 5% today; Year-to-Date: -46%
Key Issues:
Quote:
“They're down 46% year to date. Things are getting tougher and tougher in the world of UnitedHealthcare.” [05:30]
Insight:
Becker highlights the severe downturn UnitedHealthcare is experiencing, underlining the broader challenges in the healthcare industry and the company's struggle to maintain its revenue streams.
Performance: Down approximately 11% today
Key Issues:
Quote:
“We're watching that third Spotify, the podcast firm, down about 11% today and more and more challenges in their business.” [08:45]
Insight:
The decline in Spotify's stock reflects deeper issues within its business model, possibly related to competition, monetization strategies, or market saturation in the streaming sector.
Performance: Down about 10% today
Key Issues:
Quote:
“We're huge fans of UPS. We use it almost daily. They've got a great UPS right near us here where we live. We love the store. They're just a pleasure to work with.” [12:00]
Insight:
Becker’s personal endorsement of UPS contrasts with its stock performance, suggesting that while the company may be facing short-term challenges, its long-term prospects and operational excellence remain solid.
Performance: Facing a potential hit of ~$1.7 billion
Key Issues:
Quote:
“it's hard for me not to think that they're looking for excuses and to point things in different directions than reality.” [17:45]
Insight:
Becker is skeptical of Stellantis Jeep's explanations for their financial woes, suggesting that the company's prolonged poor performance is a result of mismanagement rather than just external economic factors.
Scott Becker wraps up the episode by summarizing the struggles of the five highlighted stocks, offering valuable perspectives for investors navigating these turbulent times. His insights emphasize the importance of understanding both market-driven and company-specific factors that influence stock performance.
Listeners are encouraged to reach out with suggestions or comments by texting Scott Becker at 773-766-5322, fostering an interactive community around the Becker Business Podcast.
This summary captures the key points and discussions from Episode 5 of the Becker Private Equity & Business Podcast, providing a comprehensive overview for those who have not listened to the episode.